Neuropeptide CRH prevents premature differentiation of OPCs following CNS injury and in early postnatal development
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.116474 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Clemens Ries und 18 weiteren Autor:innen. Beteiligte Einrichtung: Max Planck Institute of Psychiatry, Molecular Neurogenetics, Munich, Germany. Electronic address: clemens.ries@ki.se. Hauptthemen laut MEDLINE: Corticotropin-Releasing Hormone, Oligodendroglia, Cell Differentiation, Brain Injuries. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Max-Planck-Gesellschaft.
Abstract (Originalsprache)
The role of neuropeptides and their receptors in oligodendrocyte (OL) progenitor cells (OPCs) has been largely overlooked so far. Here, we describe a new subpopulation of corticotropin-releasing hormone (CRH)-expressing OPCs. Brain injury rapidly induces transient CRH expression in OPCs that aggregate around injury sites and exhibit an elevated capacity to differentiate into myelinating OLs. As target cells, we identified CRH receptor type 1 (CRHR1)-expressing OPCs, which show a decreased differentiation velocity. CRH/CRHR1 system inactivation increases the speed of OL generation but compromises their long-term survival after acute injury. Under non-injury conditions, CRH/CRHR1 system deficiency leads to increased early postnatal oligodendrogenesis and alterations in adult myelination. Altogether, we show that OPC-derived CRH not only actively influences the injury environment through interaction with CRHR1-expressing OPCs but also identify the G-protein coupled receptor CRHR1 as a critical modulator of oligodendrogenesis during early postnatal development with lasting effects on adult myelination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Max Planck Institute of Psychiatry, Molecular Neurogenetics, Munich, Germany. Electronic address: clemens.ries@ki.se.
- Max Planck Institute of Psychiatry, Neuroimaging Core Unit, Munich, Germany.
- Max Planck Institute of Multidisciplinary Sciences, Göttingen, Germany.
- Max Planck Institute of Psychiatry, Neural Dynamics and Behavior, Munich, Germany.
- Molecular and Translational Neuroscience, Department of Neurology, Ulm University, Ulm, Germany.
- Max Planck Institute of Psychiatry, Molecular Neurogenetics, Munich, Germany; Leibnitz Institute for Immunotherapy, Epigenetic Immunooncology, Regensburg, Germany.
Förderung
- Max-Planck-Gesellschaft
Zitieren
APA
Ries, C., Stark, T., Boulat, B., Ruhwedel, T., Delling, J. P., Infante, A. M., von Poblotzki, J. T., Ulivi, A., von Mücke-Heim, I. A., Chang, S., Sakimura, K., Itoi, K., Nestvogel, D. B., Attardo, A., Czisch, M., Nave, K. A., Möbius, W., Dimou, L., & Deussing, J. M. (2025). Neuropeptide CRH prevents premature differentiation of OPCs following CNS injury and in early postnatal development. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116474
Vancouver
Ries C, Stark T, Boulat B, Ruhwedel T, Delling JP, Infante AM, et al. Neuropeptide CRH prevents premature differentiation of OPCs following CNS injury and in early postnatal development. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116474
BibTeX
@article{Ries2025,
author = {Ries, Clemens and Stark, Tibor and Boulat, Benoit and Ruhwedel, Torben and Delling, Jan Philipp and Infante, Antonio Miralles and von Poblotzki, Julia T and Ulivi, Alessandro and von Mücke-Heim, Iven-Alex and Chang, Simon and Sakimura, Kenji and Itoi, Keiichi and Nestvogel, Dennis B and Attardo, Alessio and Czisch, Michael and Nave, Klaus-Armin and Möbius, Wiebke and Dimou, Leda and Deussing, Jan M},
title = {Neuropeptide CRH prevents premature differentiation of OPCs following CNS injury and in early postnatal development},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.116474}
}
EUVIMED